Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Aug 3, 2022
- Accession no.
- 0001447362-22-000129
- Filed
- Aug 3, 2022
- Trade date
- Aug 1-2, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 14 non-derivative transactions. Open-market sales total $245.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2022 | Common Stock | SSaleDisposed | −3,723 | $27.44F2 | −$102,159.12 | 328,814 | Direct | |
| Aug 1, 2022 | Common Stock | SSaleDisposed | −1,821 | $27.44F2 | −$49,968.24 | 148,746 | Indirect | |
| Aug 1, 2022 | Common Stock | SSaleDisposed | −1,699 | $27.44F2 | −$46,620.56 | 136,266 | Indirect | |
| Aug 1, 2022 | Common Stock | SSaleDisposed | −365 | $27.44F2 | −$10,015.6 | 30,181 | Indirect | |
| Aug 1, 2022 | Common Stock | SSaleDisposed | −364 | $27.44F2 | −$9,988.16 | 30,181 | Indirect | |
| Aug 1, 2022 | Common Stock | SSaleDisposed | −364 | $27.44F2 | −$9,988.16 | 30,181 | Indirect | |
| Aug 1, 2022 | Common Stock | SSaleDisposed | −364 | $27.44F2 | −$9,988.16 | 30,181 | Indirect | |
| Aug 2, 2022 | Common Stock | SSaleDisposed | −111 | $27.12F10 | −$3,010.32 | 328,703 | Direct | |
| Aug 2, 2022 | Common Stock | SSaleDisposed | −54 | $27.12F10 | −$1,464.48 | 148,692 | Indirect | |
| Aug 2, 2022 | Common Stock | SSaleDisposed | −51 | $27.12F10 | −$1,383.12 | 136,215 | Indirect | |
| Aug 2, 2022 | Common Stock | SSaleDisposed | −10 | $27.12F10 | −$271.2 | 30,171 | Indirect | |
| Aug 2, 2022 | Common Stock | SSaleDisposed | −11 | $27.12F10 | −$298.32 | 30,170 | Indirect | |
| Aug 2, 2022 | Common Stock | SSaleDisposed | −11 | $27.12F10 | −$298.32 | 30,170 | Indirect | |
| Aug 2, 2022 | Common Stock | SSaleDisposed | −11 | $27.12F10 | −$298.32 | 30,170 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $27.055 to $27.950, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.
- F10
This transaction was executed in multiple trades at prices ranging from $27.060 to $27.210, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.